Grupo para la caracterización molecular de las neoplasias hematológicas
Washington University in St. Louis School of Medicine
San Luis, Estados UnidosPublicacions en col·laboració amb investigadors/es de Washington University in St. Louis School of Medicine (5)
2020
-
First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma
Clinical Cancer Research, Vol. 26, Núm. 10, pp. 2308-2317
2018
-
Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics
Science, Vol. 359, Núm. 6372, pp. 191-199
2017
-
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG study
Leukemia, Vol. 31, Núm. 11, pp. 2443-2448
2016
-
A broad analysis of resistance development in the malaria parasite
Nature Communications, Vol. 7
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557